chr9-129804323-G-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014506.3(TOR1B):c.450G>T(p.Lys150Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,612,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/24 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014506.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOR1B | ENST00000259339.7 | c.450G>T | p.Lys150Asn | missense_variant | Exon 2 of 5 | 1 | NM_014506.3 | ENSP00000259339.2 | ||
TOR1B | ENST00000427860.1 | c.393G>T | p.Lys131Asn | missense_variant | Exon 2 of 3 | 3 | ENSP00000411912.1 | |||
TOR1B | ENST00000486372.1 | n.506G>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
TOR1B | ENST00000488169.1 | n.-35G>T | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000280 AC: 7AN: 250350 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000329 AC: 48AN: 1460414Hom.: 0 Cov.: 31 AF XY: 0.0000386 AC XY: 28AN XY: 726138 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.450G>T (p.K150N) alteration is located in exon 2 (coding exon 2) of the TOR1B gene. This alteration results from a G to T substitution at nucleotide position 450, causing the lysine (K) at amino acid position 150 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at